01 7Taro Pharmaceutical Industries
02 2ABRAXEOLUS
03 2ADAPTIS
04 11ANI Pharmaceuticals Inc
05 1Abdi Ibrahim
06 1Acme Lifetech
07 6Actavis Inc
08 5Alfasigma
09 2Amneal Pharmaceuticals
10 4Apotex Inc
11 3Ascent Innovative Medicines
12 2Aspire Lifesciences Pvt Ltd
13 5Bayshore Pharmaceuticals
14 2Biopharm
15 3Chartwell Pharmaceuticals llc
16 2Humanis
17 2IVAX Pharmaceuticals Inc
18 6Ipca Laboratories
19 3Myungmoon Pharm. Co., LTD.
20 4Natco Pharma
21 5Nobel Ilac Sanayii Ve Ticaret A.S.
22 2Nobel Pharmaceuticals
23 2Oxford Pharm
24 2RANBAXY LABORATORIES LIMITED
25 2SHREE HARI INTL
26 2Sandoz B2B
27 7Teva Pharmaceutical Industries
28 4Viatris
29 7Wyeth Pharmaceuticals Inc
30 2XL Laboratories Private Limited
31 3Zydus Pharmaceuticals
01 2CAPSULE
02 25CAPSULE;ORAL
03 3ER Tablet
04 6Film Coated Tablet
05 1Film-Coated Tablet
06 1Film-Coated Tablets
07 1Filmtable
08 2Granules
09 4Ret Filmtabl
10 1SR Extended Release Tablet
11 5TABLET
12 21TABLET, EXTENDED RELEASE;ORAL
13 37TABLET;ORAL
14 2Tablet
01 49DISCN
02 7Generic
03 1Generic B.E study
04 2Generic CTD, ACTD, BE
05 34RX
06 18Blank
01 2CUDIP
02 76ETODOLAC
03 1Etodin
04 2Etodolac
05 2Etodolac NOBEL retard
06 4Etol
07 1Etolax
08 2Etotac SR
09 2Etova
10 4LODINE
11 3LODINE XL
12 3Lodine 300
13 2Lodine Retard
14 7Blank
01 10India
02 3South Korea
03 7Switzerland
04 8Turkey
05 83USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET;ORAL
Dosage Strength : 400MG
Packaging :
Approval Date : 1998-03-11
Application Number : 75074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2000-04-25
Application Number : 75074
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : CAPSULE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 1998-04-30
Application Number : 75078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 1998-04-30
Application Number : 75078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 400MG
Packaging :
Approval Date : 2003-03-13
Application Number : 76174
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2003-03-13
Application Number : 76174
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 600MG
Packaging :
Approval Date : 2003-03-13
Application Number : 76174
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : CAPSULE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 1997-08-29
Application Number : 74840
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 1997-08-29
Application Number : 74840
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET;ORAL
Dosage Strength : 400MG
Packaging :
Approval Date : 1997-06-27
Application Number : 74841
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET;ORAL
Dosage Strength : 400MG
Packaging :
Approval Date : 1997-02-28
Application Number : 74819
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 1998-04-28
Application Number : 74819
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LODINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-01-31
Application Number : 18922
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LODINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 1991-01-31
Application Number : 18922
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LODINE
Dosage Form : TABLET;ORAL
Dosage Strength : 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1993-07-29
Application Number : 18922
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LODINE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1996-06-28
Application Number : 18922
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LODINE XL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1996-10-25
Application Number : 20584
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LODINE XL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1996-10-25
Application Number : 20584
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LODINE XL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-01-20
Application Number : 20584
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ETODOLAC
Dosage Form : TABLET;ORAL
Dosage Strength : 400MG
Packaging :
Approval Date : 1997-07-11
Application Number : 74839
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?